CB Insights
Technology Market Intelligence
Technology Market Intelligence
Life Sciences Partners is a venture capital firm specializing in early- to mid-stage life sciences companies.
Phone: 31 20 664 5500
Johannes Vermeerplein 9
Amsterdam, 1071 DV
Netherlands
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2021-01-14 | NewAmsterdam Pharma | Series A | $193.91M | Ascendant Capital, BVF Partners, Forbion Capital Partners, GL Capital, Janus Henderson Investors, JVC Investment Partners, Kaiser Permanente, Medpace, Morningside Technology Ventures, Peter Thiel, Population Health Partners, and Presight Capital |
| 2020-09-29 | Cardiac Dimensions | Series C | $17.5M | Aperture Venture Partners, Arboretum Ventures, Hostplus, Lumira Ventures, and M.H. Carnegie & Co. |
| 2020-08-11 | Lumeon | Series D | $30M | Amadeus Capital Partners, Endeavour Vision, Gilde Healthcare Partners, IPF Partners, MTIP AG, and Optum Ventures |
| 2020-07-29 | Vico Therapeutics | Series A | $31M | DROIA Oncology Ventures, IDInvest Partners, Kurma Partners, Polaris Partners, Pontifax, and Pureos Bioventures |
| 2020-07-29 | DNA Script | Series B - II | $50M | Agilent Technologies, Bpifrance, Casdin Capital, Danaher, Illumina Ventures, and M Ventures |
